Skip to main content
. 2018 Apr 27;57(17):2467–2472. doi: 10.2169/internalmedicine.0550-17

Table 3.

Comparison of Patients Diagnosed by Updated Criteria for Sub-clinical Cushing’s Syndrome and Those Diagnosed by Criteria Widely Used in Japan.

Patients diagnosed as sub-clinical Cushing’s syndrome by the criteria of widely used in Japan.
Sex Age
(years)
Tumor
laterality
Tumor
size
(mm)
Morning
serum cortisol
(µg/dL)
Serum cortisol
after 1mg DST
(µg/dL)
Complications
F 76 right 8 11.3 8.3 hypokalemia
F 53 left 26 10.9 6.2 hypertension
F 61 right 17 14.2 6.1 diabetes mellitus, dyslipidemia, hypokalemia
F 44 right 16 11.1 3.2 hypertension, hypokalemia
M 60 left 23 10.6 5.5 hypertension, diabetes mellitus, hypokalemia
Patients diagnosed as sub-clinical Cushing’s syndrome only by updated criteria
Sex Age
(years)
Tumor
laterality
Tumor
size
(mm)
Morning
serum cortisol
(µg/dL)
Serum cortisol
after 1mg DST
(µg/dL)
Complications
F 55 left 16 12.2 1.9 hypokalemia
F 69 right 20 12.1 1.8 hypertension
F 59 right 14 14.7 2.3 hypertension, diabetes mellitus, dyslipidemia
M 45 left 18 16.1 1.9 hypertension, diabetes mellitus, hypokalemia
F 66 left 21 12.8 1.9 hypertension, diabetes mellitus, hypokalemia

There was not significant difference between patients diagnosed only by updated criteria for SCS and those diagnosed by criteria commonly used in Japan at the point of sex, age, tumor laterality, tumor size, value of morning serum cortisol, and complications (each p>0.05). The significance of differences between means was estimated by the Student’st-test. p<0.05 was considered significant.